Risk profiles for acute health events after incident atrial fibrillation in patients With end-stage renal disease on hemodialysis

被引:12
|
作者
Airy, Medha [1 ]
Chang, Tara, I [2 ]
Ding, Victoria Y. [3 ]
Goldstein, Benjamin A. [4 ]
Bansal, Nisha [5 ]
Niu, Jingbo [1 ]
Navaneethan, Sankar D. [1 ]
Turakhia, Mintu P. [6 ,7 ]
Winkelmayer, Wolfgang C. [1 ]
机构
[1] Baylor Coll Med, Dept Med, Sect Nephrol, Selman Inst Kidney Hlth, Houston, TX 77030 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Med, Ctr Biomed Informat Res, Palo Alto, CA 94304 USA
[4] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[5] Univ Nephrol, Div Nephrol, Kidney Res Inst, Seattle, WA USA
[6] Stanford Univ, Sch Med, Dept Med, Cardiovasc Div, Palo Alto, CA 94304 USA
[7] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
arrhythmia; dialysis; mortality; myocardial infarction; stroke; MYOCARDIAL-INFARCTION; ADMINISTRATIVE DATA; STROKE; DIALYSIS; DEATH; METAANALYSIS; VALIDATION; FRACTURES; ACCURACY; OUTCOMES;
D O I
10.1093/ndt/gfx301
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Little is known about the cardiovascular risks of incident atrial fibrillation/flutter (AF) in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD). Methods. We studied older US patients who newly initiated HD for ESRD (2006-11) and who had not previously been diagnosed with AF, stroke, myocardial infarction (MI) or hip fracture. We used Cox regression with AF as a time-varying covariate, adjusted for socio-demographic characteristics and comorbidities to estimate hazard ratios [HRs (95% confidence intervals)] for the events of ischemic stroke, MI and death. Hip fracture served as a negative control outcome. Results. We identified 85 377 older patients (mean age: 76.5 years) who initiated HD; of these, 14.3% were subsequently diagnosed with AF (14.9% thereof as primary diagnosis) and 49.8% died during follow-up. Incident AF was associated with nine times higher adjusted mortality during the first 30 days [9.2 (8.8-9.6)], 5-fold higher mortality between 31 and 90 days [4.6 (4.3-4.8)] and double the mortality beyond 90 days from first AF diagnosis [2.2 (2.1-2.3)]. Incident AF was similarly associated with higher adjusted risk of ischemic stroke: 2.1 (1.62.7) during the first 30 days, 25 (2.0-3.0) between 31 and 90 days and 1.5 (1.3-1.7) beyond 90 days. Similar findings were obtained for MI. However, the risk of hip fracture was only marginally increased following AF diagnosis [<= 30 days: 1.1 (0.7-1.6); 31-90 days: 1.4 (1.0-1.8); >90 days: 1.2 (1.1-1.4)]. All associations were attenuated and the association with hip fracture was null when incident AF was defined by a primary diagnosis code. Conclusions. AF was strongly associated with increased risks of ischemic stroke, MI and death, with risks highest soon after AF diagnosis but extending beyond 90 days.
引用
收藏
页码:1590 / 1597
页数:9
相关论文
共 50 条
  • [1] Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults With Chronic Kidney Disease
    Bansal, Nisha
    Fan, Dongjie
    Hsu, Chi-yuan
    Ordonez, Juan D.
    Marcus, Greg M.
    Go, Alan S.
    [J]. CIRCULATION, 2013, 127 (05) : 569 - 574
  • [2] Atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Kokkoris, Stelios
    Liu, Tong
    Protopsaltis, Ioannis
    Li, Guangping
    Goudevenos, John A.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 (11): : 1391 - 1397
  • [3] Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Brimble, K. Scott
    Ingram, Alistair J.
    Eikelboom, John W.
    Hart, Robert G.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (06) : 17 - 25
  • [4] Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Zaman, Junaid A. B.
    Bhandari, Anil K.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 499 - 508
  • [5] Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
    van Zyl, Martin
    Abdullah, Hafez M.
    Noseworthy, Peter A.
    Siontis, Konstantinos C.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [6] The epidemiology of atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Liu, Tong
    Letsas, Konstantinos P.
    Fragakis, Nikolaos
    Kyrlas, Konstantinos
    Goudevenos, John A.
    [J]. JOURNAL OF NEPHROLOGY, 2013, 26 (04) : 617 - 623
  • [7] Circulatory endostatin level and risk of cardiovascular events in patients with end-stage renal disease on hemodialysis
    Kim, Jin Sug
    Kim, Miji
    Jeong, Kyung Hwan
    Moon, Ju -Young
    Lee, Sang Ho
    Ko, Gang Jee
    Lee, Dong -Young
    Lee, So Young
    Kim, Yang Gyun
    Hwang, Hyeon Seok
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2024, 43 (02) : 226 - 235
  • [8] Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis
    Malik, Jan
    Lachmanova, Jana
    Kudlicka, Jaroslav
    Rocinova, Katarina
    Valerianova, Anna
    Bartkova, Magdalena
    Tesar, Vladimir
    [J]. NEPHRON, 2016, 133 (03) : 169 - 174
  • [9] Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
    Koenigsbruegge, Oliver
    Ay, Cihan
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (04) : 578 - 588
  • [10] Atrial fibrillation in end-stage renal disease: an emerging problem
    Korantzopoulos, Panagiotis G.
    Goudevenos, John A.
    [J]. KIDNEY INTERNATIONAL, 2009, 76 (03) : 247 - 249